This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs

Burning Rock Biotech (BNR), a precision oncology company from China, has shown exceptional technical momentum and price appreciation. BNR has surged 405% over the past year, hitting a 2-year high on Wednesday. Despite strong technicals, BNR is a highly speculative and risky stock. Today’s Chart of the Day is not a buy recommendation. Investors should exercise caution, diversify, and use strict stop-loss strategies with BNR. Today’s Featured Stock Valued at $209 million, Burning Rock Biotech (BNR ...